Back to Search Start Over

p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel

Details

Database :
OAIster
Journal :
In: Breast Cancer Res Treat
Notes :
No full-text files, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn872083385
Document Type :
Electronic Resource